// App-Quantinova.ai

23 : Performance of the grace 2.0 score in patients with type 1 and type 2 myocardial infarction

Researchers

Presenter

  • John Hung

Principal Investigators

  • Andreas Roos

  • Erik Kadesjo

  • David McAllister

  • Anoop SV Shah

  • Atul Anand

  • Fiona E Strachan

  • Keith AA Fox

  • Nicholas L Mills

  • Martin Holzmann

  • Andrew R Chapman

Medical Centers

  • University of Edinburgh,

  • Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden

  • University of Glasgow,

  • BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

Locations

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • Grace

  • Mofezolac

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A